Aankondiging • Jun 30
Transfar Zhilian Co., Ltd. to Report First Half, 2026 Results on Aug 28, 2026 Transfar Zhilian Co., Ltd. announced that they will report first half, 2026 results on Aug 28, 2026 New Risk • Apr 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (11% operating cash flow to total debt). Minor Risks Dividend is not well covered by cash flows (114% cash payout ratio). Shareholders have been diluted in the past year (20% increase in shares outstanding). Reported Earnings • Apr 21
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: CN¥0.21 (up from CN¥0.055 in FY 2024). Revenue: CN¥25.1b (down 6.1% from FY 2024). Net income: CN¥589.7m (up 289% from FY 2024). Profit margin: 2.3% (up from 0.6% in FY 2024). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.8%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 1.8% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Aankondiging • Apr 21
Transfar Zhilian Co., Ltd., Annual General Meeting, May 27, 2026 Transfar Zhilian Co., Ltd., Annual General Meeting, May 27, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Hangzhou, Zhejiang China Aankondiging • Mar 31
Transfar Zhilian Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Transfar Zhilian Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Aankondiging • Dec 31
Transfar Zhilian Co., Ltd. to Report Fiscal Year 2025 Results on Apr 21, 2026 Transfar Zhilian Co., Ltd. announced that they will report fiscal year 2025 results on Apr 21, 2026 Reported Earnings • Oct 28
Third quarter 2025 earnings released: EPS: CN¥0.046 (vs CN¥0.019 loss in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.046 (up from CN¥0.019 loss in 3Q 2024). Revenue: CN¥6.62b (up 2.6% from 3Q 2024). Net income: CN¥127.6m (up CN¥179.7m from 3Q 2024). Profit margin: 1.9% (up from net loss in 3Q 2024). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Aankondiging • Oct 14
Transfar Zhilian Co., Ltd. Approves Interim Cash Dividend for 2025 Transfar Zhilian Co., Ltd. at its Extraordinary General Meeting of 2025 on 10 October 2025, approved interim Cash dividend/10 shares (tax included): CNY 0.500000000 for 2025. Aankondiging • Sep 30
Transfar Zhilian Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Transfar Zhilian Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Major Estimate Revision • Sep 01
Consensus EPS estimates increase by 44% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from CN¥27.6b to CN¥28.7b. EPS estimate increased from CN¥0.195 to CN¥0.28 per share. Net income forecast to grow 123% next year vs 47% growth forecast for Chemicals industry in China. Consensus price target up from CN¥5.62 to CN¥6.95. Share price was steady at CN¥6.18 over the past week. New Risk • Aug 27
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 8.9% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (8.9% operating cash flow to total debt). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Reported Earnings • Aug 26
Second quarter 2025 earnings released: EPS: CN¥0.11 (vs CN¥0.043 in 2Q 2024) Second quarter 2025 results: EPS: CN¥0.11 (up from CN¥0.043 in 2Q 2024). Revenue: CN¥6.20b (down 5.1% from 2Q 2024). Net income: CN¥312.3m (up 162% from 2Q 2024). Profit margin: 5.0% (up from 1.8% in 2Q 2024). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Aankondiging • Jul 02
Transfar Zhilian Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025 Transfar Zhilian Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 Aankondiging • May 22
Transfar Zhilian Co., Ltd. Approves Cash Dividend for 2024 Transfar Zhilian Co., Ltd. at its Annual General Meeting of 2024 on 20 May 2025, approved Cash dividend (tax included): CNY 1.00000000 per ten shares for 2024. Aankondiging • Apr 23
Transfar Zhilian Co., Ltd. Proposes Final Cash Dividend for the Year 2024 Transfar Zhilian Co., Ltd. proposed final cash dividend/10 shares (tax included) of CNY 1.00000000 for the year 2024. Board Change • Apr 22
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Jin Chen was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 22
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥0.05 (down from CN¥0.21 in FY 2023). Revenue: CN¥26.7b (down 21% from FY 2023). Net income: CN¥151.7m (down 74% from FY 2023). Profit margin: 0.6% (down from 1.8% in FY 2023). Revenue missed analyst estimates by 4.7%. Earnings per share (EPS) also missed analyst estimates by 57%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance. Aankondiging • Apr 22
Transfar Zhilian Co., Ltd., Annual General Meeting, May 20, 2025 Transfar Zhilian Co., Ltd., Annual General Meeting, May 20, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Hangzhou, Zhejiang China Aankondiging • Mar 31
Transfar Zhilian Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025 Transfar Zhilian Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025 Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥5.68, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 23% over the past three years. Aankondiging • Dec 31
Transfar Zhilian Co., Ltd. to Report Fiscal Year 2024 Results on Apr 22, 2025 Transfar Zhilian Co., Ltd. announced that they will report fiscal year 2024 results on Apr 22, 2025 Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥5.09, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 33% over the past three years. New Risk • Oct 30
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (7.5% operating cash flow to total debt). Minor Risks Dividend is not well covered by cash flows (dividend per share is over 62x cash flows per share). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.2% net profit margin). Aankondiging • Sep 30
Transfar Zhilian Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Transfar Zhilian Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥4.14, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Aankondiging • Jun 29
Transfar Zhilian Co., Ltd. to Report First Half, 2024 Results on Aug 27, 2024 Transfar Zhilian Co., Ltd. announced that they will report first half, 2024 results on Aug 27, 2024 Declared Dividend • Jun 19
Dividend of CN¥0.10 announced Dividend of CN¥0.10 is the same as last year. Ex-date: 24th June 2024 Payment date: 24th June 2024 Dividend yield will be 2.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (47% earnings payout ratio) but not covered by cash flows (dividend approximately 13x free cash flows). The dividend has remained flat since 8 years ago. However, payments have been volatile during that time. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 24
Full year 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.26 in FY 2022) Full year 2023 results: EPS: CN¥0.21 (down from CN¥0.26 in FY 2022). Revenue: CN¥33.6b (down 9.1% from FY 2022). Net income: CN¥590.9m (down 21% from FY 2022). Profit margin: 1.8% (down from 2.0% in FY 2022). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Aankondiging • Apr 23
Transfar Zhilian Co., Ltd., Annual General Meeting, May 28, 2024 Transfar Zhilian Co., Ltd., Annual General Meeting, May 28, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Hangzhou, Zhejiang China Aankondiging • Mar 30
Transfar Zhilian Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Transfar Zhilian Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥4.65, the stock trades at a trailing P/E ratio of 16.6x. Average trailing P/E is 25x in the Chemicals industry in China. Total loss to shareholders of 19% over the past three years. Aankondiging • Dec 29
Transfar Zhilian Co., Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024 Transfar Zhilian Co., Ltd. announced that they will report fiscal year 2023 results on Apr 23, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.046 (vs CN¥0.051 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.046 (down from CN¥0.051 in 3Q 2022). Revenue: CN¥8.90b (down 9.3% from 3Q 2022). Net income: CN¥120.1m (down 23% from 3Q 2022). Profit margin: 1.3% (down from 1.6% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 29
Second quarter 2023 earnings released: EPS: CN¥0.073 (vs CN¥0.098 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.073 (down from CN¥0.098 in 2Q 2022). Revenue: CN¥8.64b (down 15% from 2Q 2022). Net income: CN¥207.6m (down 30% from 2Q 2022). Profit margin: 2.4% (down from 2.9% in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 4% per year. Aankondiging • Jun 14
Transfar Zhilian Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on June 19, 2023 Transfar Zhilian Co., Ltd. announced final cash dividend of CNY 1.00 per 10 shares on A shares for the year 2022. Record date is June 16, 2023, Ex-Date is June 19, 2023 and Payment Date is June 19, 2023. Reported Earnings • Apr 26
Full year 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.72 in FY 2021) Full year 2022 results: EPS: CN¥0.26 (down from CN¥0.72 in FY 2021). Revenue: CN¥37.0b (up 4.2% from FY 2021). Net income: CN¥744.8m (down 67% from FY 2021). Profit margin: 2.0% (down from 6.3% in FY 2021). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jan 09
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥6.23, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 7.2% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥2.59 per share. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 2 independent directors (6 non-independent directors). Independent Director Jin Guo Xin was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.051 (vs CN¥0.12 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.051 (down from CN¥0.12 in 3Q 2021). Revenue: CN¥9.81b (up 4.8% from 3Q 2021). Net income: CN¥156.7m (down 60% from 3Q 2021). Profit margin: 1.6% (down from 4.2% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Major Estimate Revision • Aug 29
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 EPS estimate increased from CN¥0.70 to CN¥0.80. Revenue forecast unchanged at CN¥41.3b. Net income forecast to grow 5.5% next year vs 37% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥6.51. Share price fell 2.2% to CN¥5.71 over the past week. Reported Earnings • Aug 24
Second quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.10 (down from CN¥0.13 in 2Q 2021). Revenue: CN¥10.1b (up 14% from 2Q 2021). Net income: CN¥296.3m (down 27% from 2Q 2021). Profit margin: 2.9% (down from 4.6% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 21%, compared to a 42% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Aankondiging • Jun 23
Transfar Zhilian Announces 2021 Final Profit Distribution Plan Transfar Zhilian Co., Ltd. announced 2021 final profit distribution plan to be implemented (A shares). Cash dividend/10 shares (tax included) of CNY 1.00000000. Record date: 24 June 2022. Ex-date: 27 June 2022. Payment date: 27 June 2022. Aankondiging • May 24
Transfar Zhilian Co., Ltd. Approves Final Cash Dividend for the Year 2021 Transfar Zhilian Co., Ltd. approved final cash dividend of CNY 1.00000000 per 10 shares (tax included) for the year 2021, at its Annual General Meeting of 2021 held on 20 May 2022. Price Target Changed • May 20
Price target decreased to CN¥6.63 Down from CN¥8.46, the current price target is an average from 3 analysts. New target price is 5.7% above last closing price of CN¥6.27. Stock is down 2.6% over the past year. The company is forecast to post earnings per share of CN¥0.70 for next year compared to CN¥0.72 last year. Valuation Update With 7 Day Price Move • May 02
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥6.34, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 10.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥2.99 per share. Aankondiging • Apr 27
Transfar Zhilian Co., Ltd. Proposes Final Dividend for the Year 2021 Transfar Zhilian Co., Ltd. proposed final cash dividend of CNY 1.00000000 per 10 shares (tax included) for the year 2021. Price Target Changed • Apr 27
Price target increased to CN¥10.50 Up from CN¥8.46, the current price target is an average from 2 analysts. New target price is 74% above last closing price of CN¥6.05. Stock is down 1.9% over the past year. The company is forecast to post earnings per share of CN¥0.69 for next year compared to CN¥0.72 last year. Reported Earnings • Apr 27
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2021 results: EPS: CN¥0.72 (up from CN¥0.47 in FY 2020). Revenue: CN¥35.5b (up 64% from FY 2020). Net income: CN¥2.25b (up 48% from FY 2020). Profit margin: 6.3% (down from 7.0% in FY 2020). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 3.9%. Earnings per share (EPS) exceeded analyst estimates by 31%. Over the next year, revenue is forecast to grow 21%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Nov 19
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥9.44, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 17% over the past three years. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.06 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥9.36b (up 62% from 3Q 2020). Net income: CN¥390.1m (up 116% from 3Q 2020). Profit margin: 4.2% (up from 3.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥8.33, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 8.9% over the past three years. Price Target Changed • Sep 03
Price target increased to CN¥9.35 Up from CN¥8.34, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of CN¥9.10. Stock is up 52% over the past year. Reported Earnings • Aug 31
Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.15 in 2Q 2020) The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥8.90b (up 71% from 2Q 2020). Net income: CN¥406.6m (down 13% from 2Q 2020). Profit margin: 4.6% (down from 9.0% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥7.84, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 30% over the past three years. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥7.94, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 38% over the past three years. Aankondiging • Jun 01
Transfar Zhilian Co., Ltd. Approves Cash Dividend/10 Shares Transfar Zhilian Co., Ltd. at its AGM held on May 28, 2021 approved the Cash dividend/10 shares (tax included): CNY 1.00000000. Reported Earnings • May 02
First quarter 2021 earnings released: EPS CN¥0.042 (vs CN¥0.005 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥7.10b (up 98% from 1Q 2020). Net income: CN¥139.8m (up CN¥124.7m from 1Q 2020). Profit margin: 2.0% (up from 0.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment deteriorated over the past week After last week's 17% share price decline to CN¥6.28, the stock trades at a trailing P/E ratio of 14x. Average trailing P/E is 35x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Valuation Update With 7 Day Price Move • Mar 12
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥7.29, the stock is trading at a trailing P/E ratio of 16.2x, up from the previous P/E ratio of 13.9x. This compares to an average P/E of 35x in the Chemicals industry in China. Total return to shareholders over the past three years is a loss of 54%. Aankondiging • Mar 09
Transfar Zhilian Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021 Transfar Zhilian Co., Ltd. announced that they will report fiscal year 2020 results on Apr 20, 2021 Analyst Estimate Surprise Post Earnings • Mar 04
Revenue beats expectations, earnings disappoint Revenue exceeded analyst estimates by 2.7%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 10%, compared to a 51% growth forecast for the Chemicals industry in China. Reported Earnings • Mar 04
Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.49 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥21.9b (up 8.0% from FY 2019). Net income: CN¥1.47b (down 8.5% from FY 2019). Profit margin: 6.7% (down from 7.9% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Feb 18
New 90-day high: CN¥6.42 The company is up 15% from its price of CN¥5.60 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.53 per share. Is New 90 Day High Low • Jan 26
New 90-day high: CN¥5.82 The company is up 4.0% from its price of CN¥5.61 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.53 per share. Is New 90 Day High Low • Dec 28
New 90-day low: CN¥4.59 The company is down 21% from its price of CN¥5.80 on 29 September 2020. The Chinese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.38 per share. Is New 90 Day High Low • Dec 10
New 90-day low: CN¥5.23 The company is down 12% from its price of CN¥5.96 on 11 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.39 per share. Is New 90 Day High Low • Oct 21
New 90-day low: CN¥5.59 The company is down 6.0% from its price of CN¥5.94 on 23 July 2020. The Chinese market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.20 per share. Reported Earnings • Oct 20
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥1.44b, up 16% from the prior year. Total revenue was CN¥19.6b over the last 12 months, up 9.9% from the prior year. Aankondiging • Oct 16
Transfar Zhilian Co., Ltd. to Report Q3, 2020 Results on Oct 20, 2020 Transfar Zhilian Co., Ltd. announced that they will report Q3, 2020 results on Oct 20, 2020 Aankondiging • Oct 02
Transfar Zhilian Co., Ltd. (SZSE:002010) agreed to acquire an additional 4.58% stake in Transfar Logistics Group Co., Ltd. from ICBC Financial Asset Investment Co., Ltd. for CNY 1 billion. Transfar Zhilian Co., Ltd. (SZSE:002010) agreed to acquire an additional 4.58% stake in Transfar Logistics Group Co., Ltd. from ICBC Financial Asset Investment Co., Ltd. for CNY 1 billion on September 27, 2020. Post completion, Transfar Zhilian will own 94.12% stake in Transfar Logistics Group. Transfar Logistics Group had total assets of CNY 23.9 billion as of June 30, 2020. Transfar Logistics Group had revenue of CNY 15.1 billion, operating profit of CNY 1.3 billion and net profit of CNY 1 billion for the year ended December 31, 2019. On September 27, 2020, the 5th session of Transfar Zhilian's 7th Directorate approved the transaction. 
